Valley Pain Consultants, a division of Valley Anesthesiology Consultants, announced the relocation of its Paradise Valley office to 3301 N. Miller Road, Suite 120, Scloottsdale, AZ 85251.

Genzyme, a Sanofi company, announced today four-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate.

(Association for Research in Vision and Ophthalmology) ARVO Foundation for Eye Research congratulates the first AFER/Genentech Age-related macular Degeneration Fellowship recipients -- Balamurali K. Ambati, M.D., Ph.D., and Stephen H. Tsang, M.D., Ph.D. Each received $40,000 to support their age-related macular degeneration research and will be honored at the 2012 ...

Ligand Pharmaceuticals Incorporated announced that results from the Phase II study of its Captisol-enabled, propylene glycol-free (PG-free) Melphalan program were featured this evening in a poster presentation at the combined annual meetings of the Center for International Blood & Marrow Transplant Research (CIBMTR) and the American Society for Blood and ...

The Harper Government today announced an important investment that will help Canadians in getting more effective treatments and make the healthcare system more sustainable through personalized medicine.

Bionovo, Inc., today announced that on January 26, 2012, its Board of Directors decided to seek a voluntary delisting from the NASDAQ Capital Market.

HOLLYWOOD, Calif., Jan. 26, 2012 /- Medbox, Inc. (Pinksheets: MDBX) ( www.medboxinc.com ) announced today their new lineup of products for 2012. Through their subsidiary, Prescription Vending Machines, Inc., the company sells medicine dispensing and storage systems, which are designed to be used in hospitals, pharmacies, urgent care ...

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): Virus Structure & Assembly. This conference is an important and unique scientific conference where the intersections of virus structure with the initial events of ...

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has secured $10 million in financing with strategic accredited investors, including IDG-Accel China Growth Fund II L.P., Emerging Technology Partners, LLC, and Dr. Tak W. Mak, Director of The Campbell Family Institute for ...

The Institute of Molecular Biology (IMB) has announced a new International Summer School (ISS) in the Life Sciences. The ISS will take place from 16th July to 24th August 2012 and will provide outstanding and enthusiastic undergraduate, Master's and PhD students the opportunity to undertake exciting research projects.

PolyTherics Limited, a provider of solutions to biopharmaceutical companies for the improvement of protein and peptide based drugs, is pleased to announce the acquisition of Warwick Effect Polymers, a provider of specialty biopolymers for the modification of biological products.

New York, NY, January 19, 2012 Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce newly acquiring The Ocular Surface , a peer-reviewed journal focusing on the external eye and vision. As per January 2012 Elsevier will continue the publication ...